Authors: Meropol, NJ Sonnichsen, DS Birkhofer, MJ Ferreira, I Noel, D

Citation: Nj. Meropol et al., Bioavailability and phase II study of oral UFT plus leucovorin in patientswith relapsed or refractory colorectal cancer (vol 43, pg 221, 1999), CANC CHEMOT, 47(3), 2001, pp. 282-282

Authors: Gajjar, DA LaCreta, FP Uderman, HD Kollia, GD Duncan, G Birkhofer, MJ Grasela, DM

Citation: Da. Gajjar et al., A dose-escalation study of the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men, PHARMACOTHE, 20(6), 2000, pp. 49S-58S

Authors: Abrams, JR Lebwohl, MG Guzzo, CA Jegasothy, BV Goldfarb, MT Goffe, BS Menter, A Lowe, NJ Krueger, G Brown, MJ Weiner, RS Birkhofer, MJ Warner, GL Berry, KK Linsley, PS Krueger, JG Ochs, HD Kelley, SL Kang, SW

Citation: Jr. Abrams et al., CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris, J CLIN INV, 103(9), 1999, pp. 1243-1252

Authors: Meropol, NJ Sonnichsen, DS Birkhofer, MJ Ferreira, I Noel, D

Citation: Nj. Meropol et al., Bioavailability and phase II study of oral UFT plus leucovorin in patientswith relapsed or refractory colorectal cancer, CANC CHEMOT, 43(3), 1998, pp. 221-226